ID   BL-55
AC   CVCL_VQ30
SY   BL55; BL 55; BL 055/B95; IARC/BL55; IARC/BL 55; IARC-BL55; IARC BL55; IARC BL 55
DR   Wikidata; Q93427584
RX   PubMed=3934070;
RX   PubMed=11793449;
CC   From: International Agency of Research on Cancer (IARC); Lyon; France.
CC   Population: Caucasian.
CC   Virology: EBV-negative.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C2912; Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C152 ! BL-57
OI   CVCL_VQ31 ! IARC-205A
SX   Female
AG   40Y
CA   Cancer cell line
DT   Created: 07-09-18; Last updated: 02-05-24; Version: 7
//
RX   PubMed=3934070;
RA   Lenoir G.M., Vuillaume M., Bonnardel C.;
RT   "The use of lymphomatous and lymphoblastoid cell lines in the study of
RT   Burkitt's lymphoma.";
RL   IARC Sci. Publ. 60:309-318(1985).
//
RX   PubMed=11793449; DOI=10.1002/gcc.10022;
RA   Sobol H., Benziane A., Kerangueven F., Yin L., Noguchi T., Pauly S.,
RA   Eisinger F., Longy M., Romeo G., Lenoir G.M., Birnbaum D.;
RT   "Genome-wide search for loss of heterozygosity in Burkitt lymphoma
RT   cell lines.";
RL   Genes Chromosomes Cancer 33:217-224(2002).
//